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 T cell immunoglobulin and ITIM 
domain (TIGIT) is an inhibitory receptor 
expressed on the surface of natural killer (NK) 
cells. TIGIT recognizes nectin and nectin-like 
adhesion molecules and thus plays a critical 
role in the innate immune response to 
malignant transformation. While the TIGIT 
nectin-like protein-5 (necl-5) interaction is well 
understood, how TIGIT engages nectin-2, a 
receptor that is broadly over-expressed in 
breast and ovarian cancer, remains unknown. 
Here, we show that TIGIT bound to the 
immunoglobulin domain of nectin-2 that is 
most distal from the membrane with an affinity 
of 6 µM, which was moderately lower than the 
affinity observed for the TIGIT-necl-5 
interaction (3.2 µM). The TIGIT-nectin-2 
binding disrupted pre-assembled nectin-2 
oligomers, suggesting that receptor-ligand and 
ligand-ligand associations are mutually 
exclusive events. Indeed, the crystal structure of 
TIGIT bound to the first immunoglobulin 
domain of nectin-2 indicated that the receptor 
and ligand dock using the same molecular 
surface and a conserved “lock and key” binding 
motifs previously observed to mediate nectin-
nectin homotypic interactions as well as TIGIT-
necl-5 recognition. Using a mutagenesis 
approach, we dissected the energetic basis for 
the TIGIT-nectin-2 interaction and revealed 
that an “aromatic key” of nectin-2 is critical for 
this interaction, while variations in the lock 
were tolerated. Moreover, we found that the C-
C’ loop of the ligand dictates the TIGIT 
binding hierarchy.  Altogether, these findings 
broaden our understanding of nectin-nectin 
receptor interactions and have implications for 
better understanding the molecular basis for 
autoimmune disease and cancer.  
                                   
 
NK cells are innate lymphocytes that form the 
front line of defense towards viral infection, 
malignant transformation and damaged tissues. 
NK cell function is governed by the integration of 
signals received via an array of large receptor 
families that comprise both inhibitory and 
activating members. Examples of inhibitory NK 
cell receptors include members of the KIR (killer 
cell immunoglobulin-like receptors) and LIR 
(leukocyte immunoglobulin-like receptors) in 
humans (1) the Ly49 family in mice (2) and the 
CD94/NKG2 family in both species (3,4). These 
inhibitory receptors typically recognize major 
histocompatibility complex (MHC)-I molecules 
that are expressed on the surface of all nucleated 
cells (5-9). Accordingly, healthy cells that express 
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normal levels of MHC-I are protected from NK 
cells, whereas virally infected or transformed cells 
that have reduced MHC-I surface expression are 
susceptible to NK cell-mediated lysis. This 
process is termed “missing self” recognition (10).  
In addition to the receptors described above, NK 
cells also encode additional receptor families that 
do not bind MHC-I molecules. For example, an 
emerging group of type I cell membrane receptors 
that includes TIGIT (T cell immunoglobulin and 
ITIM domain), DNAM-1 (CD226) and CD96 
(TACTILE) specifically recognize nectin and 
nectin-like (necl) adhesion proteins (11-14).  Of 
these, TIGIT is an inhibitory receptor that is also 
expressed on subsets of regulatory and memory 
CD4+ T cells as well as CD8+ T cells. TIGIT 
possesses a single extracellular immunoglobulin 
variable (IgV) domain that is responsible for 
binding nectin-2 (CD112), nectin-3 (CD113) and 
necl-5 (CD155) (14-16). Ligand binding results in 
the phosphorylation of Tyr225 within TIGIT’s 
immunoglobulin tail tyrosine (ITT)-like motif, 
which triggers intracellular signaling cascades that 
serve to limit NK cell activation (17).  Notably, 
several viral proteins have been reported to 
downregulate both nectin-2 and necl-5 expression  
(18-20). Thus, it may be that the primary function 
of TIGIT is to mediate ‘missing self’ recognition 
of virally infected cells. However, nectin-2 and 
necl-5 are frequently upregulated in a variety of 
cancers (21-24). Here TIGIT expression can be 
counter-productive, since it directly opposes the 
activity of the activating DNAM-1 receptor, 
thereby limiting NK cell-mediated cytotoxicity of 
some tumors in vitro (2). 
 In addition to acting as ligands for nectin 
receptors, nectin and nectin-like molecules are one 
of the major constituents of adherins junctions and 
thus play a central role in a number of cellular 
processes including adhesion, migration and 
proliferation (3,4,25). Nectin and nectin-like 
protein function is dependent on their ability to 
associate into homo- and hetero-dimers both 
within the plane of the same membrane (in cis) 
and between opposing cell membranes (in trans) 
in order to form a tight network of ‘zippers’ 
between adjacent cells (4). Nectin and necl homo-
dimers are formed via interactions between the 
most membrane distal of their three extracellular 
Ig domains (D1), which contain signature “lock” 
and “key” motifs that serve to latch the molecules 
together (26). Intriguingly, these lock and key 
motifs are also conserved in the first Ig domain of 
the nectin receptors and a recent structure of 
TIGIT bound to necl-5 revealed a binding mode 
that was similar to that observed for nectin-nectin 
dimeric interactions (27). However, whether this 
docking mode is conserved in other receptor-
ligand pairings within this axis remains unclear. 
Here we present a comprehensive structural and 
biophysical analysis of the TIGIT-nectin-2 
interaction that broadens our knowledge of the 




 TIGIT binding disrupts nectin-2 
oligomerisation To study the interaction between 
TIGIT and nectin-2, we expressed and purified 
their corresponding ectodomains from E. coli and 
mammalian expression systems, respectively. 
Notably, TIGIT and nectin-2 both contain the 
signature lock and key motifs within their 
respective D1 domains (Fig 1A). Thus, to assess 
whether the recombinant TIGIT and nectin-2 
ectodomains associated in solution, we performed 
size exclusion chromatography coupled with 
multi-angle laser light scattering (SEC-MALS). 
Using this approach, nectin-2 eluted at ~1.91 ml 
and had a mass of 62 kDa, approximately twice 
that expected for a monomer based on amino acid 
sequence (36.5 kDa) (Fig. 1B). The dimeric status 
of nectin-2 is in agreement with both structural 
data and solution based studies that suggest nectin-
2 forms a stable homodimer (KD ~0.4 µM) in 
solution (26). By contrast, TIGIT eluted at a 
volume of ~2.47 ml, and had a mass of (11.9 kDa), 
in good agreement with a monomer based on 
amino acid sequence (11.7 kDa). The monomeric 
nature of TIGIT in solution was consistent with 
previous NMR and analytical ultracentrifugation 
data that suggested that the dissociation constant 
for TIGIT self-association was high (KD > 1mM) 
(27).  When TIGIT and nectin-2 were pre-mixed at 
a 1:1 molar ratio, a single peak, with a calculated 
mass of ~49 kDa was evident at 1.93 ml (Fig. 1B). 
Since this peak was well separated from that 
observed for the TIGIT monomer, we concluded it 
represented a TIGIT/nectin-2 complex (predicted 
mass 48.2 kDa) rather than a mixture of TIGIT 
monomer and nectin-2 dimer. Accordingly, 



















to associate in solution and this interaction is 
concomitant with a dissociation of the nectin-2 
homo-dimer.  
 TIGIT binds to the first Ig domain of 
nectin-2 with low micromolar affinity- While 
limited cellular staining experiments suggest 
nectin-2 is a poor ligand for TIGIT (14), our SEC-
MALS data suggested that the affinity of TIGIT 
for nectin-2 was relatively high. To formally 
assess the strength of the TIGIT-nectin-2 
interaction, we performed direct binding studies 
using surface plasmon resonance (SPR). As a 
negative control we used the structurally related 
molecule KIR2DS4, which did not bind to TIGIT 
(Fig. 1C). In contrast, the entire nectin-2 
ectodomain (EC) bound robustly to TIGIT with an 
apparent affinity (KD(app)) of 5.8 ± 0.6 µM (Fig. 
1C). While this affinity was lower than that 
observed for the binding of TIGIT to necl-5 (KD = 
3.2 ± 0.4 µM), it was at the higher end of the range 
typically observed for NK cell receptor-ligand 
interactions (e.g. KIR3DL1:HLA-B57, KD = 17 
µM (8), Ly49C:H2-Kb, KD = 80 µM (28), NKR-
P1B:m12, KD ~ 6 µM (29)), suggesting nectin-2 
represents a bona fide TIGIT ligand. Notably, the 
second and third Ig domains of nectin-2 appeared 
to be superfluous to the interaction, since a 
truncated form of nectin-2 comprising only the 
first, membrane distal Ig domain (nectin-2-D1) 
bound to TIGIT with similar affinity (KD(app) = 3.7 
± 0.5 µM) as the entire nectin-2 ectodomain (Fig. 
1C). Thus, the first Ig domain of nectin-2 mediates 
a strong interaction with TIGIT.  
 Overview of the TIGIT-nectin-2 structure-
To understand the molecular basis for the 
recognition of nectin-2 by TIGIT, we determined 
the crystal structure of TIGIT bound to nectin-2-
D1 to 3.1 Å resolution (Table I). The structure 
refined very well, to an Rfac/Rfree of 21.4/23.0 
respectively, and the electron density at the 
TIGIT/nectin-2 interface was unambiguous, 
thereby permitting a detailed understanding of the 
molecular interactions that underpin the 
interaction. The crystallographic asymmetric unit 
comprised two molecules of TIGIT and two 
molecules of nectin-2 that together formed a 
symmetrical double-winged structure (Fig. 2A). 
Within this heterotetrameric arrangement, the two 
TIGIT molecules form the ‘body’ (see discussion) 
whereas the nectin-2 molecules lie at the 
extremities and correspond to the ‘wings’.  
           Both TIGIT and nectin-2 D1 adopted β-
sandwich folds (sheet 1: ABED, sheet 2: 
C’’C’CFG) and possess a strand topology that is 
classical of the Ig-variable domain superfamily 
(30). Accordingly, TIGIT and nectin-2 D1 are 
closely structurally conserved, with a root mean 
square deviation (r.m.s.d.) of 1 Å over 80 aligned 
Cα atoms. While the TIGIT and nectin-2 
secondary structure elements superpose well, the 
two molecules differ in the size and conformation 
of the connecting loops. In particular, the C-C’ and 
D-E loops are markedly extended (by 15 and 5 
residues respectively) in nectin-2, thereby 
allowing us to confidently verify the identity of 
each molecule within the electron density map 
(Fig. 2B and 2C). Neither TIGIT nor nectin-2 D1 
underwent significant conformational changes 
upon complex formation (TIGIT r.m.s.d 0.42 Å 
over 96 Cα atoms, nectin-2 r.m.s.d. 0.35 Å over 
111 Cα atoms) compared to their previously 
published unliganded forms (PDB IDs 3Q0H and 
4DFH (31)). A sugar moiety derived from the 
mammalian expression system is visible at the 
single predicted N-linked glycosylation site (Asn 
137) on the F-strand of one of the nectin-2 
protomers and does not impact on TIGIT binding 
(Fig. 2A).  
 The TIGIT-nectin-2 interface- TIGIT and 
nectin-2 D1 interacted over a broad region that 
encompassed the breadth of their corresponding 
C’’C’CFG sheets as well as the interconnecting 
C’’C’ and FG loops (Fig. 3). The total solvent 
accessible surface area that was buried upon the 
interaction was 1,560 A2. The relatively small 
interface was offset however by a high degree of 
shape complementarity (SC = 0.74, where an SC 
value of 1 represents a geometrically perfect fit), 
which is considerably greater than that typically 
observed for other NK cell receptor-ligand 
interactions such as Ly49C-H2-Kb (0.58) (28) or 
NKG2A/CD94-HLA-E (0.63) (32). The 
interactions at the TIGIT-nectin-2 interface are 
primarily non-polar in nature, with a total of 7 H-
bonds and only a single solitary salt-bridge (Table 
II). The primary points of contact are derived from 
signature AX6G ‘lock’ and TF/YP ‘key’ 
interactions derived from the C’C’’ and FG loops, 
respectively. Since TIGIT and nectin-2 possess 
both a ‘lock’ and a ‘key’, these motifs form 
complementary interactions that serve to latch the 



















prominent aromatic residue of the key (Tyr 113 in 
TIGIT and Phe145 in nectin-2) inserts into a 
concave hydrophobic pocket, making extensive 
interactions with both main chain and side chain 
atoms within, and directly after, the AX6G lock 
(Ala67-Gly74 in TIGIT and Ala83-Gly90 in 
nectin-2) (Fig. 3A and 3B). The lock and key 
interactions, which reside at the periphery of the 
interface, are further supplemented by additional 
contacts primarily derived from residues on the 
face of the more centrally located C-, C’- and F-
sheets (Fig. 3C). Here, the side chains of the 
second and third positions of a semi-conserved 
VTQ motif (ISL in nectin-2) appear to play a 
prominent role. In particular, Thr55 (in TIGIT) 
forms a bridge between the C’ and C sheets while 
Gln56 extends towards the F-strand forming H-
bonds with the hydroxyl of Ser 66 and the 
carbonyl of Thr 144 (Fig 3C). 
 Structural Comparisons- The architecture 
of the TIGIT-nectin-2 structure is closely related 
to that previously observed for TIGIT bound to 
necl-5 D1 (27), as well as that reported for 
nectin/necl homo- and hetero-dimers (26) (Fig. 
4A). For example, the r.m.s.d between 
TIGIT:nectin-2 D1 and TIGIT:necl-5 D1 is 1.48 Å 
over all Cα atoms. In addition to the overall 
docking mode, the molecular interactions at the 
TIGIT-nectin-2 interface, namely those derived 
from the aromatic key, hydrophobic lock and 
I/V,S/T,L/Q motif,  mirror those observed in 
TIGIT:necl-5 as well as reported for receptor-
receptor (TIGIT:TIGIT) and ligand-ligand (nectin-
2:nectin-2) homodimers. Despite this 
conservation, subtle differences at the interfaces 
can also profoundly impact binding affinity. For 
example, whereas nectin-2 forms a tight 
homodimer (KD = 0.4 µM), TIGIT self-association 
is very weak (KD > 1 mM). Moreover, necl-5 
binds to TIGIT with higher affinity than that of 
nectin-2 (Fig. 1C). To understand the structural 
basis for the differing affinities of nectin-2 and 
necl-5 for TIGIT, we overlaid their corresponding 
structures. While the vast majority of the structural 
elements at the interface overlaid closely, we 
observed a notable difference in the conformation 
of the C-C’ loop (Fig 4B). In necl-5 this region 
was closely associated with TIGIT, resulting in a 
cluster of H-bonding contacts derived from the 
necl-5 residue Ser74 to the carbonyl groups of 
Pro114 and Asp115 of TIGIT (Fig 4B). In nectin-2 
however, the C-C’ loop flexed away from TIGIT 
such that contacts in this region were limited to 
only a single nectin-2 residue (Asn81). 
Accordingly, the TIGIT-nectin-2 structure 
provided a plausible explanation for the difference 
in affinity of nectin-2 and necl-5 for TIGIT.  
 Energetic basis of the TIGIT-nectin-2 
interaction- To further probe the molecular details 
underpinning TIGIT-nectin-2 specificity we 
generated a series of nectin-2 mutants and 
assessed their binding to immobilized TIGIT using 
SPR (Fig. 5). In tandem we also measured the 
thermostability of each nectin-2 construct in order 
to gain insight as to whether the mutations 
impacted the stability of the molecules (Table III). 
As a negative control we included a mutation 
(E101A) within a surface exposed loop that was 
remote from the TIGIT binding site. As expected, 
the E101A mutation did not inadvertently impact 
TIGIT binding (KD(app) = 4.9 ± 0.5 µM) or the 
stability of nectin-2 (melting temperature (TM) = 
67.2°C compared to 68.6°C for wild type). In 
contrast, mutation of the nectin-2 aromatic key 
(F145A) completely abolished TIGIT binding, 
suggesting this residue was absolutely critical for 
the interaction. However, mutation of residues 
within the lock whose side chains project towards 
the key (H86A, M89A) only moderately reduced 
TIGIT binding (KD(app) = 21.0 ± 1.3 µM and 8.7 ± 
1.5 µM respectively), indicating that interaction of 
the key with the TIGIT backbone and/or residues 
outside the lock (e.g. Ser92 in nectin-2) may play 
important roles in the interaction. Next we tested 
the impact of mutations of the conserved alanine 
and glycine residues that cap the AX6G lock. Here, 
a G90A mutation severely impacted TIGIT 
binding (KD(app) = 47.0 ± 10 µM) whereas 
substitution of Ala83 for Val was relatively well 
tolerated (KD(app) = 8.8 ± 1.3 µM). However, a less 
conservative A83R substitution resulted in an ~11 
fold reduction in TIGIT binding (KD(app) = 66 ± 4.0 
µM). Notably, all of the Ala83 and Gly90 mutants 
were considerably less stable (TM < 61°C) than 
wild type nectin-2, suggesting they may play a 
role in maintaining the structural integrity of the 
lock. We also assessed the relative importance of 
certain residues at the center of the TIGIT-nectin-2 
interface, outside of the canonical lock and key 
motifs. Here, mutation of L67A within the 
I/V,S/T,L/Q reduced TIGIT binding by ~4 fold 



















E141 that forms the solitary salt-bridge at the 
interface, did not impact binding (KD(app)  = 4.9 ± 
0.4 µM). Finally we sought to determine whether 
the differing affinity of nectin-2 and necl-5 for 
TIGIT was indeed caused by the C-C’ loop, as 
suggested by the TIGIT-nectin-2 structure. To this 
end we engineered a mutant form of nectin-2 
where the C-C’ loop was replaced by that of necl-
5. This chimeric construct bound to TIGIT with an 
affinity that was more similar to necl-5 than 
nectin-2 (KD(app)  = 2.3 ± 0.2 µM) indicating that 
the necl-5 C-C’ loop was able to engender nectin-2 
with necl-5-like binding capacity. In contrast, 
mutation of nectin-2 residue L67 to a Gln (as 
found in necl-5) did not impact TIGIT binding 
affinity (KD(app)  = 5.6 ± 0.6 µM).  
 
DISCUSSION 
 The nectin receptors TIGIT, DNAM-1 and 
CD96 are emerging as key regulators of NK cell 
function due to their ability to specifically 
recognize certain nectin and nectin-like adhesion 
molecules. For example, TIGIT and DNAM-1 
bind to nectin-2 and necl-5, while TIGIT also 
recognizes nectin-3 (16,33,34). CD96 also shares 
the necl-5 ligand in common with TIGIT and 
DNAM-1, but additionally binds to nectin-1 
(16,35). These receptor-ligand interactions not 
only facilitate adhesion of NK cells to their 
targets, but also deliver important signals to the 
NK cell. 
 Here we have performed a comprehensive 
structural and biophysical analysis of the TIGIT-
nectin-2 interaction. We found that TIGIT bound 
relatively tightly to the nectin-2 ectodomain, and 
that this interaction was dependent solely on the 
most membrane distal nectin-2 Ig domain. The 
structure of TIGIT bound to nectin-2 D1 revealed 
a heterotetrameric assembly where two central 
TIGIT molecules were flanked by two nectin-2 
protomers. Each nectin-2 D1 engaged a single 
TIGIT via an interface that was markedly similar 
to that previously observed for TIGIT-necl-5 and 
well as for nectin-2-nectin-2 and necl-5-necl-5 
homotypic interactions (26,27). This conservation 
in docking mode between receptor-ligand and 
ligand-ligand interactions suggests these binding 
events are mutually exclusive. Indeed, our MALS 
data confirmed that while nectin-2 normally forms 
a stable homo-dimer in solution, only monomeric 
nectin-2 is capable of TIGIT binding. This finding 
suggests that TIGIT is likely able to capture 
nectin-2 on the cell surface, even if nectin-2 is 
only transiently accessible due to tight homotypic 
interactions within the plane of the same 
membrane (in cis). Indeed, in our SPR 
experiments, binding of nectin-2 to immobilized 
TIGIT was likely in direct competition with 
nectin-2 self-association. For this reason, we 
report the affinity of the TIGIT:nectin-2 
interaction as KD(app). 
 Intriguingly, the packing of receptor and 
ligand into a heterotetrameric assembly as 
observed here was identical to that previously 
reported for TIGT-necl-5, despite differences in 
the spacegroup and unit cell dimensions between 
the two structures (27). In both cases, two TIGIT 
molecules associated laterally via their respective 
A’ strands to form a centrally located homo-dimer 
that is flanked by the ligand on each side. The 
recurrence of these structural features might 
suggest that such an arrangement of receptor and 
ligand may have physiological relevance outside 
the bounds of the crystal environment. Indeed, 
previous studies have suggested that TIGIT self-
associates on the cell membrane in cis and 
mutations at the TIGIT-TIGIT homo-dimer have 
been reported to inhibit CD155 signaling (27). 
However, modeling of the TIGIT:nectin-2 hetero-
tetramer suggested that this arrangement is 
unlikely to accommodate a trans interaction 
without a large scale conformational change, 
although a partially occupied form (TIGIT homo-
dimer bound to a single nectin-2 molecule) could 
potentially bridge two opposing cell membranes 
(Fig. 6A). Alternatively, the TIGIT:nectin-2 
hetero-tetramer might also exist in cis (Fig. 6B). 
 In order to understand the underlying 
energetic basis for TIGIT-nectin-2 interactions we 
employed an extensive mutagenesis approach. 
Here, substitutions of the conserved alanine or 
glycine residues that cap the AX6G lock severely 
impacted TIGIT binding. Notably, mutations here 
also considerably reduced the thermostability of 
nectin-2, suggesting that these residues are 
important for maintaining the structural integrity 
of the lock. This interpretation is consistent with 
the associated structural data that indicates these 
residues point inwards, rather than outwards 
towards TIGIT. Notwithstanding this, the A83V 
mutation did not appreciably impact TIGIT 



















represents a defining feature of these receptor and 
ligand families, can potentially accommodate 
some variability.  
Surprisingly, we observed little to no 
effect when mutating the residues within the 
nectin-2 lock, despite these representing the main 
point of contact for the aromatic key (F145), the 
mutation of which completely abrogated binding. 
Although somewhat unexpected, an inspection of 
the sequence conservation within the AX6G lock 
of the nectin receptors and their ligands (Fig 1A) 
indicates that the physio-chemical properties of the 
amino acids located within this region is quite 
diverse. Thus, rather than their exact nature, the 
presence of any amino acid side chains that can 
accommodate the key may be the defining factor 
that dictates a productive interaction.  
Finally, we show that the C-C’ loop of the 
ligand as the major factor governing TIGIT 
binding hierarchy. Notably, this was the only 
region that differed appreciably between the first 
Ig domain of the two TIGIT ligands, nectin-2 and 
Necl-5. The nectin-2 C-C’ loop protruded away 
from TIGIT, making only limited contacts in 
contrast to that of necl-5, where it formed an 
extensive interface. Substitution of the nectin-2 C-
C’ loop for that of necl-5 improved the affinity of 
nectin-2 for TIGIT, such that it bound with a 
similar affinity as necl-5. It will be interesting to 
determine if this region similarly impacts binding 
to the other nectin receptors, CD96 and DNAM-1.   
 
EXPERIMENTAL PROCEDURES 
Protein Expression and Purification- The gene 
encoding human TIGIT (encoding amino acid 
residues 22-128) harboring a mutation of the free 
cysteine residue (C69S) was cloned into NdeI and 
NheI restriction sites of the pET30 vector and 
expressed as inclusion bodies in TonA- BL-21 
Esherichia coli cells as previously described for 
MHC-I (36). For SPR studies a BirA sequence 
was inserted at the TIGIT carboxy terminus. 
TIGIT was refolded by dilution in a solution 
containing 4M Urea, 0.4M L-arginine, 0.1M 
EDTA, 0.1M Tris-HCl pH 8.0 in 5:1 mM 
reduced:oxidised glutathione overnight at 4°C. 
Refolded TIGIT was dialysed in 10 mM Tris pH 
8.0 and purified via a combination of anion 
exchange (using DEAE and HiTrapQ columns) 
and size exclusion chromatography using a 
Superdex75 16/60 column (GE Healthcare). For 
biotinylation, BirA tagged TIGIT was buffer 
exchanged into 10 mM Tris pH 8.0 and 
biotinylated overnight at 4 °C as previously 
described (37). The genes encoding the first Ig 
domain (D1: residues 32-158) and the full length 
ectodomain (EC: residues 32-350) of human 
nectin-2 were cloned into a modified version of 
the pHLSec vector with C-terminal thrombin 
cleavable 6x histidine tag. Recombinant nectin-2 
constructs were expressed via transient 
transfection in human embryonic kidney two 
hundred and ninty three-S cells as described 
previously (38). Secreted protein was concentrated 
and buffer exchanged into 10 mM Tris pH 8.0 
containing 500mM NaCl and purified via nickel-
affinity and size-exclusion chromatography using 
Superdex 200 16/60 columns (GE Healthcare). All 
nectin-2 mutants were generated within the 
context of the entire ectodomain by splice-by-
overlap PCR and expressed and purified as 
described above. The entire ectodomain of human 
necl-5 (residues 28-334) was cloned into a 
modified version of the pFastBac vector  
(Invitrogen) with a C-terminal 6x His tag. Soluble 
necl-5 was expressed in Hi5 insect cells according 
to the manufacturers’ instructions and purified as 
described above for nectin-2.   
 Size Exclusion-Coupled Multi Angle Light 
Scattering (SEC-MALS)- 50 µL of TIGIT, nectin-
2-EC or a 1:1 molar ratio of the two proteins at 40 
µM were resolved on a Superdex200 5/150 
column (GE Healthcare) in 10 mM Tris pH 8.0, 
150 mM NaCl at a flow rate of 0.3 mL/min. The 
system was comprised of DGU-20A5 degasser, 
LC-20AD liquid chromatograph, SIL-20AC HT 
auto sampler, CBM-20A communications bus 
module, SPD-20A UV/vis detector and CTO-
20AC column oven (Shimadzu) coupled with a 
DAWN HELIOS-II light scattering detector and 
Optilab T-rEX refractive index detector (Wyatt). 
Detector number 12 was substituted for a 
WyattQELS detector installed at a 90° angle. The 
system was controlled using LC-solutions 
(Shimadzu) and data collection and analysis were 
performed ASTRA6 (Wyatt Technology Corp.). 
 Surface Plasmon Resonance (SPR)- SPR 
experiments were performed using a BIAcore 
3000 system (GE Healthcare) at 25 °C using a 
buffer comprising 10 mM Tris, pH 8.0, 150 mM 
NaCl and 0.005% surfactant P20. Approximately 



















immobilised onto streptavidin coated Sensorchips 
(GE Healthcare) using standard procedures. All 
flow cells were quenched with free biotin prior to 
injection of analytes. Soluble necl-5-EC, nectin-2 
EC, nectin-2 D1 and mutants thereof were passed 
over the flow cells in duplicate at a flow rate of 10 
µL/min. The final response was calculated by 
subtracting the response of an “empty” flow cell 
(containing biotin blocked streptavidin). Data 
collection and analysis was performed using 
BIAevaluation (GE Healthcare) and Prism 
(GraphPad). Responses from independent 
experiments were normalized such that the 
maximal response was defined as 100.  
 Crystallisation and Data Collection-
Purified TIGIT and nectin-2 D1 were mixed at a 
1:1 molar ratio at a total protein concentration of 8 
mg/mL. Crystals were obtained using the hanging-
drop vapour diffusion method from a solution 
containing 1.3 M lithium sulfate and 0.1 M Tris, 
pH 7.0. Prior to data collection, crystals were 
cryoprotected in 0.1 M Tris, pH 7.0, 1.6 M lithium 
sulfate and 30% glycerol before being flash-frozen 
in liquid nitrogen. X-ray diffraction data was 
recorded on a Quantum-315 CCD detector at the 
MX2 beamline of the Australian Synchrotron. 
Data were integrated by MOSFLM and scaled 
using SCALA within the CCP4 suite of programs. 
Details of the data processing statistics are given 
in Table I.  
 Structure Determination and Refinement- 
The structure was determined by molecular 
replacement using Phaser. Monomeric forms of 
TIGIT and nectin-2 D1, both in unliganded form 
were used as search models (PDB ID’s 3UCR and 
3R0N, respectively). Because TIGIT and nectin-2 
exhibit a large degree of structural similarity, omit 
maps of the refined structures after deletion of the 
CC’ and DE loops served to validate the identity 
of the molecules within the crystal lattice. The 
final structure was solved to reveal a 
heterotetrameric complex of two TIGIT-nectin-2 
dimers and refined to a final Rfac of 21.4% and Rfree 
23.0%. Details of the data collection and 
refinement statistics are in Table I. The TIGIT-
nectin-2 structure has been deposited with the 
Protein Data Bank (PDB code: 5V52). 
 Thermal Melt- The thermal stability of the 
nectin-2 and mutants thereof was assessed using 
Rotor Gene Q real-time PCR (Qiagen). Protein 
samples were added to SYPRO Orange Protein 
Gel Stain (Sigma Aldrich) at a final concentration 
of 0.5 mg/mL and were held at 29 °C for 150 s 
before the temperature was increased to 90 °C in 1 
°C increments. Fluorescence was measured using 
the yellow channel with the source at 530 nm, 
detector at 555 nm and gain of 5. Data acquisition 
and analysis was done using Rotor Gene Q series 
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Table 1. X-ray crystallographic data collection and refinement statistics. 
 
Data collection statistics  
Temperature (K) 100 
X-ray source MX2 Australian Synchrotron 
Spacegroup P43212 
Cell dimensions 68.50, 68.50, 253.91  
 90, 90, 90 
Resolution (Å) 85-3.1 (3.27-3.1) 
Total number of observations 81489(12229) 
No. unique observations 11784(1677) 
Multiplicity 6.9(7.3) 
Data completeness 99.8(100) 
I/σI 6.3(1.7) 
Rpim (%) 9.6(41) 
CC(1/2) 0.986(0.532) 
Refinement statistics  
Non-hydrogen atoms  
   Protein 3418 
   Sugar 25 
1
Rfactor (%) 21.4 
Rfree (%) 23 
r.m.s.d from ideality  
   Bond lengths (Å) 0.007 
   Bond angles (°) 0.96 
Ramachandran plot  
   Favoured regions (%) 97.3 
   Allowed regions (%) 2.4 
   Disallowed regions (%) 0.3 
B factor, all atoms  (Å2) 71 
 
1





















Table II. Contacts between TIGIT and nectin-2. 
 
TIGIT Nectin-2 Type 
Thr55CG2 Ser66CB,O VDW 
Thr55OG1,CG2,OG1 His86NE2,CD2 VDW 
Gln56OE1 Ser66OG H-Bond 
Gln56 NE2,CB,CD,OE1 Ser66OG,OG,CB VDW 
Gln56NE2 Ala143CB,C VDW 
Gln56OE1 Thr144O H-Bond 
Gln56NE2,CD,OE1 Thr144N,O,C VDW 
Gln56OE1 Phe145CB VDW 
Asn58ND2 Ser149OG H-Bond 
Asn58ND2 Ser149N,CB VDW 
Glu60OE1 Ser149OG,CB VDW 
Ile68CG2 Phe145CD2 VDW 
Ile68CD1 Pro146O,C VDW 
Ile68CD1 Gly148CA,N VDW 
Asn70ND2 Ser66CB VDW 
Asn70CB Phe145CD2,CE2 VDW 
Asp72OD2 Tyr64OH VDW 
Leu73CD1 Tyr64CB,CG,CD2 VDW 
Leu73CB,CD1 Phe145CD1,CE1,CB,CG,CZ VDW 
Gly74O Phe145CZ,CE2 VDW 
Trp75O Phe145CZ VDW 
His76CB Phe145CZ,CE2 VDW 
His76CG,CD2,ND1,CE1,NE2 Pro146CB,O VDW 
His111CE1 Glu141OE1 VDW 
His111ND1 Glu141OE1 Salt-Bridge 
His111CG,CD2,ND1 Ala143CB VDW 
His111NE2 Ser149OG H-Bond 
His111CE1 Ser149OG VDW 
Thr112N,O Leu67CD2 VDW 
Tyr113CB,CG,CD1,CE1 His86CD2,CB VDW 
Tyr113CD2,CE2, CZ,OH Met89CB,CG,SD,O VDW 
Tyr113CE1,CZ,OH Gly90O,C VDW 
Tyr113OH Pro91O H-Bond 
Tyr113CZ,OH Pro91O,C VDW 



















Pro114O Ser92OG H-Bond 
Pro114CA,C,CB Ser92OG,CB VDW 
Pro114O Pro94CB,CG VDW 
Asp115O Asn81ND2,CB,CG VDW 
Asp115C,O Pro94CG,CB VDW 
Gly116CA,C Asn81CG,ND2,OD1 VDW 
Thr117OG1 Thr69CB,CG2,OG1 VDW 
Thr117OG1,CB Gln71NE2 VDW 
Thr117N Asn81OD1 H-Bond 
Thr117N,CA,CB,O Asn81CG,OD1,ND2 VDW 
Thr117OG1,CG2 Glu141OE1 VDW 
 
 
Atomic contacts were determined with CONTACT available within the CCP4i package. Van der Waals 
interactions were defined as non-hydrogen bonded contacts up to a distance of 4 Å. Hydrogen bond and 
salt bridge interactions were defined as contact distances of less than 3.5 Å or 4.5 Å respectively.  
 
 
Table III. Thermal stability of nectin-2 mutants.  
 
Construct  TM (°C)  ± SEM  Motif  
WT  68.61 0.10 -  
L67A  67.87 0.19 VTQ  
L67Q  68.58 0.14 VTQ  
A83V  60.68 0.88 Lock  
A83R  55.31 0.11 Lock  
H86A  61.79 0.51 Lock  
M89A  66.68 0.10 Lock  
G90A  57.15 0.37  Lock  
E101A  67.23 0.43 Control  
E141A  66.48 0.09 Salt bridge  
F145A  65.49 0.25 Key  
Loopswap  66.52 0.18 C-C' loop  
 
TM = melting temperature. Data are representative of two independent thermal melt experiments, each run 





















FIGURE 1. TIGIT-nectin-2 binding. (A) Sequence alignment of the three conserved motifs found within 
nectin receptors and their ligands. (B) Mass measurements and elution profiles of TIGIT, nectin-2 and an 
equimolar mixture of TIGIT and nectin-2 determined by SEC-MALS. The protein species corresponding 
to each mass measurement is depicted schematically on the right. (C) SPR sensograms (top) and 
equilibrium binding curves (bottom) are shown for the interaction between soluble nectin-2 EC, nectin-2 
D1, necl-5 EC and KIR2DS4 against immobilised TIGIT. SPR sensograms are representative of a single 
experiment. Equilibrium binding curves were derived from n independent experiments as denoted. 
KD/KD(app) and standard error of the mean (SEM, depicted as error bars) were calculated from the 
independent experiments. NB indicates no binding.  
 
FIGURE 2. Overview of the TIGIT-nectin-2 structure. (A) Cartoon representation of the TIGIT-nectin-2 
hetero-tetramer.  The aromatic key residues (sticks) and the AX6G locks (denoted by red dashed 
rectangles) are highlighted for a single TIGIT-nectin-2 interaction. Electron density maps of the TIGIT 
and nectin-2 DE (B) and C-C’ (C) loops. The final refined 2Fo-Fc map (blue mesh) and an Fo-Fc omit 
map (green mesh) are shown contoured at 1σ and 3σ respectively. 
 
FIGURE 3. Molecular interactions at the TIGIT-nectin-2 interface. (A) The key of TIGIT (slate) docking 
within the lock of nectin-2 (gold) and (B) the key of nectin-2 docking within the lock of TIGIT. The 
conserved alanine and glycine residues that cap the pockets are highlighted in bold. (C) Interactions 
involving the (V/I)(S/T)(Q/L) motif. For context, the key residues of nectin-2 (F145) and TIGIT (Y113) 
are also shown as sticks. Black dashed lines indicate hydrogen bonds, blue dashed line denote salt 
bridges. 
 
FIGURE 4. A conserved docking mode in nectin receptors and their ligands. (A) Comparison of the 
docking modes of nectin receptor-receptor, receptor-ligand and ligand-ligand complexes. Molecules  are 
colored as follows: TIGIT (slate/blue), nectin-2 (gold/sand), necl-5 (purple/magenta). PDB accession 
codes (from left to right): 5V52, 3UDW, 3RQ3, 4DFH, 4FQP. (B) Overlay of TIGIT (slate) bound to 
nectin-2 (gold) and necl-5 (purple) with a view focused on the C-C’ loop. The boxed region is magnified 
on the right, with residues that form direct contacts represented as sticks. Dashed lines indicate hydrogen 
bonds. 
 
FIGURE 5. Binding of nectin-2 mutants to TIGIT. SPR sensograms (top rows) and the equilibrium 
binding curves (bottom rows) of mutants of nectin-2 EC binding to immobilised TIGIT. SPR sensograms 
are representative of a single experiment. Equilibrium binding curves were derived from 3 (for C-C’ 
Loop-swap) or 2 (for all others) independent experiments. KD/KD(app) and standard error of the mean 
(SEM, depicted as error bars) were calculated from the independent experiments. NB indicates no 
binding.   
 
FIGURE 6. Models of potential TIGIT:nectin-2 arrangements on the cell surface. Models were generated 
using the nectin-1 ectodomain (orange and gold, PDB accession code: 4FMF). A 2 TIGIT: 2 nectin-2 
heterotetramer is consistent with a cis arrangement (A), whereas a 2 TIGIT: 1 nectin-2 stoichiometry 
could be accommodated in trans (B). Dark grey boxes represent transmembrane domains, blue/red boxes 
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